Search

everythinglearnresearchcommunity

for

Search:↓

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

Normal human melanocytes can avoid cell death through multiple pathways.

Imiquimod cream can rarely cause temporary hair loss.

A woman with severe angioedema improved significantly after treatment with rituximab.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Anti-TNF therapy can cause hair loss and skin issues.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Tip cryotherapy effectively treats idiopathic guttate hypomelanosis with minimal side effects.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Upadacitinib may effectively treat alopecia areata without side effects.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Nab-paclitaxel chemotherapy can rarely cause lupus-like skin issues.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.